SCHEMBL2279102

SCHEMBL2279102

CCC1(CC)CCNC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28017220 0.87 TSHR (0.33)
SCHEMBL15601032 0.85
SCHEMBL12526915 0.85
SCHEMBL14860422 0.85 CYP2D6 (0.33)
SCHEMBL17642692 0.85
SCHEMBL11008857 0.84 SOS1 (0.31)
SCHEMBL443124 0.82 OPRM1 (0.31)
SCHEMBL21515959 0.82 TSHR (0.30)
SCHEMBL14753708 0.82 SOS1 (0.34)
SCHEMBL23606901 0.82 TSHR (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 108 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2885279-A1 CYCLOPENTYLPYRAZOLES AS N-TYPE CALCIUM CHANNEL BLOCKERS Janssen Pharmaceutica, N.V. (BE) 2015-06-24 EP claimed
WO-2014028801-A1 CYCLOPENTYLPYRAZOLES AS N-TYPE CALCIUM CHANNEL BLOCKERS JANSSEN PHARMACEUTICA NV (BE) 2014-02-20 WO claimed
WO-2013177292-A1 TITANIUM-CONTAINING PRECURSORS FOR VAPOR DEPOSITION L'AIR LIQUIDE, SOCIETE ANONYME POUR L'ETUDE ET L'EXPLOITATION DES PROCEDES GEORGES CLAUDE (FR) 2013-11-28 WO claimed
WO-2013177284-A1 HAFNIUM-CONTAINING PRECURSORS FOR VAPOR DEPOSITION L'AIR LIQUIDE, SOCIETE ANONYME POUR L'ETUDE ET L'EXPLOITATION DES PROCEDES GEORGES CLAUDE (FR) 2013-11-28 WO claimed
WO-2013177269-A2 ZIRCONIUM-CONTAINING PRECURSORS FOR VAPOR DEPOSITION L'AIR LIQUIDE, SOCIETE ANONYME POUR L'ETUDE ET L'EXPLOITATION DES PROCEDES GEORGES CLAUDE (FR) 2013-11-28 WO claimed
US-20250381187-A1 KRAS G12C INHIBITORS AND METHODS OF USING THE SAME AMGEN INC. (US) 2025-12-18 US disclosed
US-20250340565-A1 CD73 INHIBITOR COMPOUNDS ADORX THERAPEUTICS LTD (GB) 2025-11-06 US disclosed
US-12440491-B2 KRAS G12C inhibitors and methods of using the same AMGEN INC. (US) 2025-10-14 US disclosed
EP-4532495-A1 CD73 INHIBITOR COMPOUNDS Adorx therapeutics Limited (GB) 2025-04-09 EP disclosed
CN-119585273-A CD73 inhibitor compounds 阿道尔克斯治疗有限公司 2025-03-07 CN disclosed
US-20240359168-A1 Mesoporous Catalyst Compounds and Uses Thereof EXXONMOBIL RESEARCH AND ENGINEERING COMPANY 2024-10-31 US disclosed
US-12064752-B2 Mesoporous catalyst compounds and uses thereof ExxonMobil Technology and Engineering Company (US) 2024-08-20 US disclosed
EP-1891951-A1 Viral polymerase inhibitors BOEHRINGER INGELHEIM (CANADA) LTD. (CA) 2008-02-27 EP disclosed
US-5300654-A Dehydrating beta-hydroxyketone in presence of acid catalyst NIPPON SODA CO., LTD. (JP) 1994-04-05 US disclosed
EP-0457911-B1 PREPARATION METHOD FOR ALPHA,BETA-UNSATURATED KETONES NIPPON SODA CO., LTD. (JP) 1993-09-01 EP disclosed
US-5214151-A Method for the preparation of α, β-unsaturated ketones NIPPON SODA CO., LTD. (JP) 1993-05-25 US disclosed
EP-0457912-A1 METHOD FOR THE PREPARATION OF $g(a),$g(b)-UNSATURATED KETONES NIPPON SODA CO., LTD. (JP) 1991-11-27 EP disclosed
EP-0457911-A1 PREPARATION METHOD FOR ALPHA,BETA-UNSATURATED KETONES. NIPPON SODA CO (JP) 1991-11-27 EP disclosed
WO-1991007371-A1 METHOD FOR THE PREPARATION OF α,β-UNSATURATED KETONES NIPPON SODA CO., LTD. (JP) 1991-05-30 WO disclosed
WO-1991007368-A1 PREPARATION METHOD FOR α,β-UNSATURATED KETONES NIPPON SODA CO., LTD. (JP) 1991-05-30 WO disclosed